Yuichi Iwaki
Co-Founder, Interim CFO, President, CEO & ChairmanDr. Yuichi Iwaki, M.D., Ph.D., is a Co-Founder of MediciNova Inc. and has been its Chief Executive Officer and President since March 2006 and as Chairman. Dr. Iwaki served as Acting Principal Financial Officer at MediciNova, Inc. from April 22, 2020 until June 2020 and serves as its Interim CFO since November 11, 2026. Dr. Iwaki is a Partner of Biotech Healthcare Partners, Inc. He was an Advisor of JAFCO Co., Ltd. He has been advising pharmaceutical companies and venture capital funds regarding research and investment strategies and is a Board Member of several biotechnology companies. He served as an Acting Chief Financial Officer and Acting Chief Accounting Officer of MediciNova Inc. from November 8, 2013 to April 2014. He served as an Acting Chief Executive Officer of MediciNova since September 2005 and its Acting Chief Financial Officer from September 2005 to November 2011. He served as the Chairman of MediciNova Inc., from September 26, 2000 to March 30, 2007 and was its Executive Chairman since July 2005. He was a Director of Avigen since November 1994 until 2008 Dr. Iwaki serves as a Director at Biotech Healthcare Partners, Inc. He has been an Executive Director of MediciNova, Inc. since September 26, 2000. From September 2001 until January 2007, Dr. Iwaki also served as consultant at MediciNova Inc. in connection with financing transactions and business development activities. He is a Director of the Transplantation Immunology and Immunogenetic Laboratory since 1992 and Intercept Pharmaceuticals, Inc. Dr. Iwaki is also a visiting professor at the Toho University School of Medicine. He is also a Member of Advisory Board of Two River Group Holdings, LLC. He served as a Director at Antyra, Inc. He has held three professorships at University of Southern California School of Medicine in the departments of urology, pathology and surgery since 1992. He is a Professor in the Department of Urology, Surgery and Pathology at Keck School of Medicine. In addition, Dr. Iwaki holds visiting professorships at the University of California, Irvine, School of Medicine; Nihon University School of Medicine, Kyushu University; and the Tokyo Women's Medical School in Japan. Prior to joining the University of Southern California School of Medicine faculty in 1992, he held professorships at the University of Pittsburgh in the Departments of Surgery and Pathology from 1989 through 1991. Dr. Iwaki is the author of more than 200 peer-reviewed publications and more than 40 books. He received a Ph.D. and an M.D. from Sapporo Medicine School in Sapporo.
公司职务
- 公司名称MediciNova, Inc.股票代码MNOV职务Co-Founder, Interim CFO, President, CEO & Chairman
